2023-05-25
Biopharmaceutical company came good news, recently, the emerging biopharmaceutical to add important product approval: goslings plague refined egg yolk antibody veterinary medicine word 190032118.
Gosling plague, also known as goose parvovirus infection, is an acute or subacute infectious disease caused by goose parvovirus in newborn goslings or Muscovy ducks. It has the characteristics of rapid transmission, high morbidity and fatality rate. Gosling plague virus is an autonomous virus, self-replicating, can be transmitted through the environment, can also be vertically transmitted, so that the eggs carry the virus, the goslings, young Muscovy duck immune system does not have the immune function of automatically clearing such viruses.
Because it takes a certain time for goslings or muscovducks to produce immune response after vaccination, passive immunization with purified egg yolk antibody of gosling plague and specific neutralization of gosling plague virus is a very effective method for gosling and Muscovducks to prevent gosling plague.
The acquisition of the production approval number is the company has always adhered to the concept of "be an animal health expert, serve human health", and continued to increase research and development investment, filling the gap of the company's antibody products, enriching the waterfowl product line, and bringing new performance growth points.